Table 1.
Study | Vector Products |
Gene-Modified T Cell Lines |
Patient Follow-Up Studies |
|||
---|---|---|---|---|---|---|
RCL | RCR | RCL | RCR | RCL | RCR | |
Bear et al., 20124 | – | 42 vector lots negative | – | 297 negative | – | 629 negative |
Cornetta et al., 20175 | 26 vector lots negative | – | 460 negative | – | 296 negative | – |
Marcucci et al., 20172 | 15 vector lots negative | 2 vector lots negative | 351 negative | 24 negative | 288 negative | 20 negative |
Lyon et al., 20173 | – | 9 vector lots negative | – | 266 negative | – | 549 negative |
Total | 41 negative | 53 negative | 811 negative | 587 negative | 584 negative | 1495 negative |